MALAT1 and cervical cancer: Results of transfection efficiency were assessed as in Figures 2(a) and 2(c)–2(f), illustrating that transfection of LV-shMALAT1 in cervical cancer cells significantly decreased the LncRNA MALAT1 level, whereas LV-MALAT1 overexpressed it compared with the End/E6E cell line.